Mode
Text Size
Log in / Sign up

Maternal steroid hormones in early pregnancy linked to birth outcomes in Chinese cohortEvery parent wants a healthy start for their child

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note exploratory associations between maternal steroid hormones and birth outcomes; findings require validation and do not indicate causation.

This was a prospective cohort study of 364 pregnant women in Guangzhou, China. The study measured 19 maternal steroid hormones in early pregnancy using LC-MS/MS and examined associations with adverse birth outcomes (ABOs), including low birth weight, macrosomia, small for gestational age (SGA), large for gestational age, and preterm birth.

For birth length, each 1-SD increase in cortisol was associated with an increase of 0.18 cm (95% CI: 0.02, 0.34). For head circumference, each 1-SD increase in cortisol was associated with an increase of 0.24 cm (95% CI: 0.04, 0.44). For gestational age, each 1-SD increase in estrone was associated with a decrease of 0.20 weeks (95% CI: -0.36, -0.05).

For ABOs, each 1-SD increase in androstenedione was associated with higher odds (OR = 1.36, 95% CI: 1.07, 1.72), as was testosterone (OR = 1.37, 95% CI: 1.08, 1.73) and dihydrotestosterone (OR = 1.32, 95% CI: 1.03, 1.69). An inverse association was seen with 11-deoxycortisol (OR = 0.70, 95% CI: 0.50, 0.98). For SGA, androstenedione (OR = 1.40, 95% CI: 1.01, 1.94) and testosterone (OR = 1.47, 95% CI: 1.08, 1.99) were associated with increased risk, while cortisol (OR = 0.84, 95% CI: 0.72, 0.97) and 11-deoxycortisol (OR = 0.58, 95% CI: 0.35, 0.95) were inversely associated. An androgen mixture was associated with ABOs (OR = 1.40, 95% CI: 1.00, 1.97) and SGA (OR = 1.77, 95% CI: 1.04, 3.01).

Safety and tolerability were not reported. Key limitations include the exploratory nature of the findings, which require validation in larger cohorts, and the lack of reported follow-up duration. The study design does not allow for causal inference. Clinicians should interpret these associations cautiously, recognizing they are preliminary and not yet actionable for practice.

Every parent wants a healthy start for their child. But sometimes, things happen that doctors cannot predict. New science is looking at invisible signals inside the body. These signals travel through blood before birth. They might hold the key to understanding complications.

Birth complications affect thousands of families every year. Conditions like low birth weight or early delivery cause worry. Doctors need better tools to spot risks before they happen. Many parents feel helpless when they cannot control the outcome. Understanding the root cause gives families a sense of control. It helps them prepare for potential challenges ahead.

The Surprising Shift in Research

We used to focus mostly on stress hormones. But here’s the twist: sex hormones play a role too. This study changes how we look at early pregnancy. Previously, researchers thought only cortisol mattered for growth. Now we see that other chemical messengers are involved. The mix of hormones seems to matter more than one alone.

How Hormones Work Inside the Body

Think of hormones as messengers in your bloodstream. They tell your body how to grow and heal. Too much of one type can throw off the balance. Imagine a traffic jam where cars move too fast. The baby’s development needs a steady flow of nutrients. Hormones act like the traffic lights for this flow. When the lights change, the speed of growth changes.

Study Snapshot and Method Details

Researchers followed 364 pregnant women in China. They measured nineteen different steroid hormones early in pregnancy. The goal was to see which levels matched health issues. This group was carefully tracked from the start. Data was collected using advanced blood testing methods. Scientists looked at the first few months of pregnancy.

What They Found in the Data

Women with higher testosterone levels had more risks. This included issues like small size for the baby. Cortisol levels were linked to longer birth length. Specific male-type hormones were linked to adverse outcomes. Lower levels of certain stress chemicals were also noted. High levels of androgens increased the chance of problems. This pattern held true across different types of risks.

This doesn’t mean this treatment is available yet.

Expert Perspective on the Findings

Scientists call these findings exploratory and preliminary. They suggest a pattern but do not prove cause. More data is needed to confirm these links. Experts urge caution before making major health changes. This is a clue, not a final diagnosis. It opens a door for future medical research.

You cannot change your hormone levels on your own. Do not panic if you hear about these numbers. Keep talking to your doctor about your pregnancy care. Routine checkups are still the best way to stay safe. Trust your medical team to guide your decisions. Your doctor knows your full health history best.

This group was small and from one city. Results might look different in other populations. Early research often needs bigger teams to verify. The study did not test every possible hormone. We need more diverse groups to be sure. Cultural and genetic differences can change the results.

The Road Ahead for Science

Next steps involve larger studies across different countries. Approval for new tests takes years of safety checks. Science moves slowly to ensure it helps everyone safely. Future research will focus on how to fix imbalances. Patience is key while we wait for answers. We hope to turn these findings into real help soon.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundAdverse birth outcomes (ABOs) are major public health concerns. While maternal steroid hormones are essential for fetal development, their individual and combined effects on ABO remain unclear.MethodsThis prospective cohort study included 364 pregnant women (30.7 ± 4.0 years) in Guangzhou, China. Nineteen steroid hormones were measured by LC-MS/MS. Regression and Qgcomp models were used to assess individual and combined associations with ABO, including low birth weight, macrosomia, small for gestational age (SGA), large for gestational age, and preterm birth.ResultsPregnant women with ABO had higher levels of androstenedione (A4) and testosterone (T) and lower levels of 11-deoxycortisol (11-DOF) and estriol (E3). In linear regression models, each 1-SD increase in cortisol (F) was associated with increases of 0.18 cm (95% CI: 0.02, 0.34) in birth length and 0.24 cm (95% CI: 0.04, 0.44) in head circumference, whereas estrone (E1) was inversely associated with gestational age (−0.20 weeks, 95% CI: −0.36, −0.05). In logistic regression analyses, each 1-SD increase in A4 (OR = 1.36, 95% CI: 1.07, 1.72), T (OR = 1.37, 95% CI: 1.08, 1.73), and dihydrotestosterone (DHT) (OR = 1.32, 95% CI: 1.03, 1.69) was associated with higher odds of ABO, whereas 11-DOF was inversely associated with ABO (OR = 0.70, 95% CI: 0.50, 0.98). For SGA, each 1-SD increase in A4 (OR = 1.40, 95% CI: 1.01, 1.94) and T (OR = 1.47, 95% CI: 1.08, 1.99) was associated with increased risk, whereas F (OR = 0.84, 95% CI: 0.72, 0.97) and 11-DOF (OR = 0.58, 95% CI: 0.35, 0.95) were inversely associated. In Qgcomp analyses, the androgen mixture was associated with ABO (OR = 1.40, 95% CI: 1.00, 1.97) and SGA (OR = 1.77, 95% CI: 1.04, 3.01), with A4 and T contributing the largest weights. Consistent directional patterns were observed for androgen-related hormones across outcomes and analytical approaches.ConclusionsMaternal hormonal milieu in early pregnancy may be associated with fetal growth and ABO risk, with consistent patterns for androgen-related hormones. These findings are exploratory and require validation in larger cohorts.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.